Terms of use
Last reviewed:
These terms govern your access to the website operated by Braxylonthap for Quoralis-related information.
Operator details
Braxylonthap, Valtakatu 23, 96200 Rovaniemi, Finland. Contact identifiers listed in the footer appear as plain text.
Geographic scope and audience
These terms apply to users worldwide. Mandatory consumer or privacy rules in your country of residence may give you rights that cannot be waived by this text.
Google Ads and third-party platforms
If you reach this site through an advertisement, the advertising platform’s terms and privacy notices apply to that interaction. Our pages are informational; they must not be read as a promise of how any product will perform for you.
Advertising and food supplement content
You must not use our site or communications to publish unsubstantiated health claims, guarantee results, or present Quoralis as a treatment for disease. Listings should follow responsible standards for food supplements and paid advertising.
Informational nature
Content is provided for general information about a food supplement. It does not replace professional advice tailored to your health or legal situation.
Acceptable use
You agree not to misuse the site, attempt unauthorized access, or submit unlawful or harmful content through forms.
Orders and availability
Product availability, pricing, and shipping rules depend on the checkout flow that applies at the time of purchase. Inquiry forms do not create a binding contract until confirmed separately.
Intellectual property
Text, layout, and branding elements are owned by the operator or licensors. You may not copy or redistribute them without permission.
Limitation of liability
To the extent permitted by law, the operator is not liable for indirect losses or consequential damages arising from site use. Mandatory consumer rights under Finnish law remain unaffected.
Governing law
Finnish law applies to these terms. Courts in Finland have jurisdiction unless mandatory rules provide otherwise.
Changes
We may update these terms. Continued use after changes constitutes acceptance of the revised version.